OMEPRAZOLE EXTENDED
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The Defense Logistics Agency has awarded DMS PHARMACEUTICAL GROUP INC under contract SPE2DP26F4181 for the delivery of OMEPRAZOLE EXTENDED, identified by NSN 6505016247068, as part of a larger delivery order under contract SPE2DX25D9900. The award was posted on DIBBS on July 21, 2026, with an effective award date of April 7, 2026, and the total contract value is detailed in the official award documentation. The contract is issued under federal procurement authority, with the Department of Defense as the overseeing agency, and no specific set-aside or NAICS code designations are indicated. Performance location and point of contact details are not specified, but the contract is active under U.S. federal jurisdiction with no foreign delivery requirements noted. The awardee, identified by CAGE code 1UNB0, is obligated to fulfill the specified pharmaceutical delivery under the terms of this procurement.
General Info
Agency
NAICS
Place of Performance
Not specifiedSet-Aside
Documents
(3)AI Contract Breakdown
Uniform Contract FormatWhat is UCF?
Uniform Contract Format (UCF) uses AI to break down any contract into standardized sections—scope, pricing, deliverables, and evaluation criteria.
Timeline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Defense → Defense Logistics Agency
Same awarding agency
Ready to Pursue This Opportunity?
Get AI-powered intelligence on this solicitation and the ones like it
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 650+ contractors already using CLEATUS
